BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21503901)

  • 1. FBXW7 mutations typically found in human cancers are distinct from null alleles and disrupt lung development.
    Davis H; Lewis A; Spencer-Dene B; Tateossian H; Stamp G; Behrens A; Tomlinson I
    J Pathol; 2011 Jun; 224(2):180-9. PubMed ID: 21503901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines.
    Davis H; Lewis A; Behrens A; Tomlinson I
    Gut; 2014 May; 63(5):792-9. PubMed ID: 23676439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDC4/FBXW7 and the 'just enough' model of tumourigenesis.
    Davis H; Tomlinson I
    J Pathol; 2012 Jun; 227(2):131-5. PubMed ID: 22323043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.
    Fujii Y; Yada M; Nishiyama M; Kamura T; Takahashi H; Tsunematsu R; Susaki E; Nakagawa T; Matsumoto A; Nakayama KI
    Cancer Sci; 2006 Aug; 97(8):729-36. PubMed ID: 16863506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
    Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
    Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas.
    Jen KY; Song IY; Banta KL; Wu D; Mao JH; Balmain A
    Blood; 2012 Jan; 119(3):805-9. PubMed ID: 22117044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.
    King B; Trimarchi T; Reavie L; Xu L; Mullenders J; Ntziachristos P; Aranda-Orgilles B; Perez-Garcia A; Shi J; Vakoc C; Sandy P; Shen SS; Ferrando A; Aifantis I
    Cell; 2013 Jun; 153(7):1552-66. PubMed ID: 23791182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver.
    Onoyama I; Suzuki A; Matsumoto A; Tomita K; Katagiri H; Oike Y; Nakayama K; Nakayama KI
    J Clin Invest; 2011 Jan; 121(1):342-54. PubMed ID: 21123947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FBXW7 beta-form is suppressed in human glioma cells.
    Gu Z; Inomata K; Ishizawa K; Horii A
    Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fbxw7/hCdc4 tumor suppressor in human cancer.
    Tan Y; Sangfelt O; Spruck C
    Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.
    Xu Y; Sengupta T; Kukreja L; Minella AC
    J Biol Chem; 2010 Nov; 285(45):34439-46. PubMed ID: 20826802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
    Asnafi V; Buzyn A; Le Noir S; Baleydier F; Simon A; Beldjord K; Reman O; Witz F; Fagot T; Tavernier E; Turlure P; Leguay T; Huguet F; Vernant JP; Daniel F; Béné MC; Ifrah N; Thomas X; Dombret H; Macintyre E
    Blood; 2009 Apr; 113(17):3918-24. PubMed ID: 19109228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.
    Wang Y; Zhang P; Wang Y; Zhan P; Liu C; Mao JH; Wei G
    Cancer Res; 2017 Apr; 77(8):1983-1996. PubMed ID: 28209614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses.
    Dolly SO; Gurden MD; Drosopoulos K; Clarke P; de Bono J; Kaye S; Workman P; Linardopoulos S
    Br J Cancer; 2017 Sep; 117(7):954-964. PubMed ID: 28829765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability.
    Kemp Z; Rowan A; Chambers W; Wortham N; Halford S; Sieber O; Mortensen N; von Herbay A; Gunther T; Ilyas M; Tomlinson I
    Cancer Res; 2005 Dec; 65(24):11361-6. PubMed ID: 16357143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FBXW7 mutations in melanoma and a new therapeutic paradigm.
    Aydin IT; Melamed RD; Adams SJ; Castillo-Martin M; Demir A; Bryk D; Brunner G; Cordon-Cardo C; Osman I; Rabadan R; Celebi JT
    J Natl Cancer Inst; 2014 Jun; 106(6):dju107. PubMed ID: 24838835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation.
    Babaei-Jadidi R; Li N; Saadeddin A; Spencer-Dene B; Jandke A; Muhammad B; Ibrahim EE; Muraleedharan R; Abuzinadah M; Davis H; Lewis A; Watson S; Behrens A; Tomlinson I; Nateri AS
    J Exp Med; 2011 Feb; 208(2):295-312. PubMed ID: 21282377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of FBXW7 in Gynecologic Malignancies.
    Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Suleiman S; Vasileva-Slaveva M; Yordanov A; Pentimalli F; Giordano A; Calleja-Agius J
    Cells; 2023 May; 12(10):. PubMed ID: 37408248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.
    Mansour MR; Sulis ML; Duke V; Foroni L; Jenkinson S; Koo K; Allen CG; Gale RE; Buck G; Richards S; Paietta E; Rowe JM; Tallman MS; Goldstone AH; Ferrando AA; Linch DC
    J Clin Oncol; 2009 Sep; 27(26):4352-6. PubMed ID: 19635999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of BRAF protein stability by a negative feedback loop involving the MEK-ERK pathway but not the FBXW7 tumour suppressor.
    Hernandez MA; Patel B; Hey F; Giblett S; Davis H; Pritchard C
    Cell Signal; 2016 Jun; 28(6):561-71. PubMed ID: 26898828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.